Seeking Covid Pills, Poor Nations Fear Repeat of AIDS Crisis
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.
Category: Generic Brands and Products
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs.
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs.
Competition for market share at rock-bottom prices has led to shortages, price spikes, allegations of price-fixing and substandard and even dangerous practices.
Competition for market share at rock-bottom prices has led to shortages, price spikes, allegations of price-fixing and substandard and even dangerous practices.
Competition for market share at rock-bottom prices has led to shortages, price spikes, allegations of price-fixing and substandard and even dangerous practices.
Competition for market share at rock-bottom prices has led to shortages, price spikes, allegations of price-fixing and substandard and even dangerous practices.
Competition for market share at rock-bottom prices has led to shortages, price-spikes, allegations of price-fixing, and substandard and even dangerous practices.
Biologic drugs rack up billions in annual U.S. sales. Here’s a solution to lower the costs.
Biologic drugs rack up billions in annual U.S. sales. Here’s a solution to lower the costs.
Biologic drugs rack up billions in annual U.S. sales. Here’s a solution to lower the costs.
Biologic drugs rack up billions in annual U.S. sales. Here’s a solution to lower the costs.
Biologic drugs rack up billions in annual U.S. sales. Here’s a solution to lower the costs.